Health
Researchers are developing first prognostic, therapeutic epigenetic biomarker for pancreatic cancer patients – News-Medical.Net
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths…
By 2030, pancreatic ductal adenocarcinoma (PDAC), the most lethal form of pancreatic cancer, is projected to become the second leading cause of cancer-related deaths in the United States.
Not only are therapeutic options limited, but nearly half of all PDAC patients who have their tumors removed surgically experience disease recurrence within a year, despite receiving additional chemotherapy. For more advanced stages, only about one-third of patients have a limited response to approved chemotherapy.
…
-
Noosa News23 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General22 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Noosa News11 hours agoNSW farmer calls for hunting buffer zones after bullets hit property